Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Bee Vectoring Technologies International Inc C.BEE

Alternate Symbol(s):  BEVVF

Bee Vectoring Technologies International Inc. is a Canada-based agriculture technology company. The Company is focused on the control of pests and enhancement of crops and ornamentals through the use of biological controls in a variety of application processes. It operates a natural precision agriculture system that replaces chemical pesticides and wasteful plant protection product spray... see more

CSE:BEE - Post Discussion

Bee Vectoring Technologies International Inc > BVT CEO's history. Repeating?
View:
Post by John99 on Apr 26, 2021 2:49pm

BVT CEO's history. Repeating?

Will Ashish Malik's past involvement in succesful enterprises be demonstrated once
again with BVT ?  For anyone looking at BVT and present investors ...

Researching a companies leadership and their past endeavours, successful or 
otherwise, gives an important perspective of it's future potential success. Experienced, knowledgable leadership and clearly stated realistic, viable company objectives are crucial to secure the confidence of investors. 

When I began investing in BVT in 2019 apart from recognizing the obvious potential value of what has been developed and marketed, the following information was a major influence in committing to holding long term and continuing to accumulate shares. S/P fluctuations are not a deterent, but in my perspective an opportuity for further accumulation. 

In 2011 Ashish Malik was the Senior Vice President of Global Marketing and a member of the executive team with Agraquest, a supplier of biological pest control products.
Agraquest's revenue in 2011 was $40 million

A year later...
 
In 2012 Bayer Cropscience with revenues of  €1.8 billion in 2011 purchased Agraquest for approximately $500 million !!  which included milestone payments and Ashish Malik joined their team as Vice President of Global Marketing for Biologics.  
 
BVT continues to expand in North America, increasing revenues, while continuing to progress into international market venues. Solid, experienced leadership. 

I maintain a sense of caution and continually investigate whatever I invest in. I look for negatives, warning lights (I can't find any here) and I don't speculate on future price increases, I look for value. 

It's been some time since I've seen this kind of investment potential with such proprietary tech combined with the type of leadership we have in BVT.  It's wonderful being in on basically the ground floor.  

The following are the links to the above inforrmation. I've posted some of this before.

GLTA

  
https://cambridgehouse.com/extraordinary-future/speaker/ashish-malik

https://www.marketwatch.com/story/bayer-buys-agraquest-adds-to-biopesticide-lines-2012-07-04

https://www.cropscience.bayer.ca/en/

https://www.sacbee.com/news/business/article98792357.html
Comment by robertwfb on Apr 26, 2021 3:45pm
nice summation John. I hope to buy more but tapped out right now. If the gold market should ever take off I'll be moving some of that money here.
Comment by aldarion8484 on Apr 26, 2021 7:33pm
Great post.  Thanks
Comment by kulewater on Apr 27, 2021 11:10am
Awesome. I too would put myself in the 'value investor' bucket. I have fairly strict criteria when I look for value plays that are under the radar. This one checks all the boxes for me. I love the space and the ESG potential for attracting funds. As always execution is key at this stage of the game.  I love the IP portfolio, the business model, the management team - Ashish is very ...more  
Comment by John99 on Apr 27, 2021 12:53pm
Kulewater re: "The only caveat I have is that they will likely need to raise money to fund growth in the very short term..." Yes, that's always a possibilty but there are a few buffers that might help minimize that potential. Also the takeout target...  highly likely.. BVT has the only game with this tech but as they've said (webinar) they aren't going around shopping ...more  
Comment by kulewater on Apr 27, 2021 2:31pm
Agreed on all accounts.  Based on their current COH and burn rate I still think its more likely. Not a bad thing neccessarily especially if its done as a bought deal. This will bring at least one analyst to the table. I would be looking to also participate in this kind of raise. Lots to look forward to here. Lets keep the conversation going.. before the noise shows up.  Cheers.
Comment by John99 on Apr 27, 2021 5:01pm
Can't argue that.. $929k increase on investor and PR last year but directed at and well spent on Europe and the U.S. Analyst(s) would be wonderful, as this really hasn't hit the media yet I think they'd latch on for how "green" this tech is.  Indeed lots to look forward to...  Noise? What do you think? Will CR7 work on noise and trolls? This board is a pleasure ...more  
Comment by kulewater on Apr 27, 2021 6:07pm
Will CR7 work on noise and trolls?    Dare to dream.. that in of itself would put the MC into the blue chip tier. Another exciting thing to consider is how they can x-sell 3rd party biologicals and vice-versa.  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities